Cancer chemotherapy and antioxidants.
Conklin
Kenneth A
KA
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095-1778, USA. kconklin@mednet.ucla.edu
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors; D000975:Antioxidants / Q000008:administration & dosage* / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D003067:Coenzymes; D004317:Doxorubicin / Q000009:adverse effects; D004347:Drug Interactions; D005978:Glutathione / Q000008:administration & dosage; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D018384:Oxidative Stress; D017382:Reactive Oxygen Species; D016896:Treatment Outcome; D014451:Ubiquinone / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D000975:Antioxidants; D003067:Coenzymes; D017382:Reactive Oxygen Species; D014451:Ubiquinone; D004317:Doxorubicin; C024989:coenzyme Q10; D005978:Glutathione; D002945:Cisplatin